耐药性癫痫患者中[18F]FDG、[18F]FMZ与[18F]SynVesT-1正电子发射断层成像的头对头比较
回顾性纳入11例耐药性癫痫患者,均行[18F]FDG、[18F]FMZ和[18F]SynVesT-1 PET显像。基于AAL图谱的视觉评估显示,[18F]FDG低代谢区域显著广于[18F]FMZ和[18F]SynVesT-1,后两者间无统计学差异。癫痫起病年龄与[18F]SynVesT-1摄取减低相关,而与[18F]FMZ或[18F]FDG摄取无关。
要点
- 在11例耐药性癫痫患者中,[18F]FDG PET低代谢范围显著大于[18F]FMZ和[18F]SynVesT-1 PET。
- [18F]FMZ与[18F]SynVesT-1 PET所示摄取减低范围无统计学差异(p>0.05)。
- 癫痫起病年龄与[18F]SynVesT-1摄取减低相关(r=0.7397,p=0.0145)。
核心结论
- 在耐药性癫痫患者中,[18F]FMZ和[18F]SynVesT-1 PET所示摄取减低模式较[18F]FDG PET更为局限。
- 癫痫起病年龄与[18F]SynVesT-1摄取减低相关,而与[18F]FMZ或[18F]FDG摄取无关。
研究设计与样本
- 回顾性纳入11例耐药性癫痫患者,均接受[18F]FDG、[18F]FMZ和[18F]SynVesT-1 PET显像。
- 采用AAL图谱进行视觉评估计数异常代谢脑区,并行体素水平分析描绘异常代谢分布。
- 分析低代谢分布与癫痫起病年龄的关系。
主要发现
- [18F]FDG PET在AAL图谱中识别的低代谢区域显著广于[18F]FMZ(p=0.0005)和[18F]SynVesT-1(p=0.0010),[18F]FMZ与[18F]SynVesT-1间无统计学差异(p>0.05)。
- [18F]FDG PET的体素数量在低强度区和严重低强度区均显著高于[18F]FMZ和[18F]SynVesT-1 PET。
- 两区域体素数量比值在[18F]SynVesT-1 PET高于[18F]FDG PET(p=0.0195)和[18F]FMZ PET(p=0.0237),且与癫痫起病年龄正相关(r=0.7397,p=0.0145)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The loss of synaptic vesicle glycoprotein 2 A (SV2A) can lead to dysfunction of GABAergic neurons, but a direct comparison of SV2A and GABAA receptor densities in humans has not been assessed. This study evaluated SV2A and GABAA receptor abnormalities in patients with drug-resistant epilepsy (DRE) and compared the patterns to glucose hypometabolism. METHODS: Eleven patients with DRE were retrospectively recruited and underwent PET imaging with [18F]fluorodeoxyglucose ([18F]FDG), [18F]Flumazenil (FMZ), and [18F]SynVesT-1. Visual assessments counted abnormal metabolic brain regions based on the Anatomical Automatic Labeling (AAL) atlas, while voxel-level analyses delineated the abnormal metabolic distributions. The relationship between hypo-metabolic distributions and the age of epilepsy onset was analyzed. RESULTS: The hypometabolic regions in [18F]FDG PET, identified in the AAL atlas, was significantly broader than in [18F]FMZ (p = 0.0005) and [18F]SynVesT-1 (p = 0.0010) PET, with no statistical difference observed between [18F]FMZ and [18F]SynVesT-1 PET (p > 0.05). The voxel number in [18F]FDG PET was significantly higher than that of the [18F]FMZ and [18F]SynVesT-1 PET in both hypo-intensity area and severe hypo-intensity area. The ratio of the voxel number between these two area was higher for [18F]SynVesT-1 PET compared to [18F]FDG PET (p = 0.0195) and [18F]FMZ PET (p = 0.0237), and positively correlated with the age of epilepsy onset (r = 0.7397, p = 0.0145). CONCLUSIONS: [18F]FMZ and [18F]SynVesT-1 PET images revealed a more restricted pattern of reduced uptake compared to [18F]FDG PET in DRE patients. The age of epilepsy onset correlated with a reduction in [18F]SynVesT-1 uptake but not in [18F]FMZ or [18F]FDG uptake.
引用
- Li G, Lin Z, Bao W, et al. Head-to-Head comparison of [18F]FDG, [18F]FMZ, and [18F]SynVesT-1 positron emission tomography imaging in patients with drug-resistant epilepsy. Eur J Nucl Med Mol Imaging. 2025. PMID: 39888422. doi:10.1007/s00259-025-07111-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。